These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 10404337
1. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study. Soussy CJ, Cluzel M, Ploy MC, Kitzis MD, Morel C, Bryskier A, Courvalin P. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337 [Abstract] [Full Text] [Related]
2. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates]. Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J. Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192 [Abstract] [Full Text] [Related]
3. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study]. Soussy CJ, Morel C, Kitzis MD, Meyran M, Brun Y, Joly-Guillou ML, Dabernat H, Chanal M, Courtieu AL, Derlot E. Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670 [Abstract] [Full Text] [Related]
4. In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalis. Kitzis MD, Goldstein FW, Miegi M, Acar JF. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():21-6. PubMed ID: 10404333 [Abstract] [Full Text] [Related]
8. [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve]. Soussy CJ, Cluzel M, Meyran M. Pathol Biol (Paris); 1995 Apr; 43(4):274-80. PubMed ID: 7567114 [Abstract] [Full Text] [Related]
12. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Frémaux A, Sissia G, Geslin P. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331 [Abstract] [Full Text] [Related]
13. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections. Casellas JM, Gilardoni M, Tome G, Goldberg M, Ivanovic S, Orduna M, Dolmann A, Ascoli M, Ariza H, Montero JM. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336 [Abstract] [Full Text] [Related]
16. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve]. Soussy CJ, Cluzel M, Derlot E, Kitzis MD, Meyran M. Pathol Biol (Paris); 1994 May; 42(5):385-92. PubMed ID: 7824301 [Abstract] [Full Text] [Related]
17. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010]. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Levofloxacin-Surveillance Group. Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294 [Abstract] [Full Text] [Related]